Your browser doesn't support javascript.
loading
Hepatocyte-Specific Loss of PPARγ Protects Mice From NASH and Increases the Therapeutic Effects of Rosiglitazone in the Liver.
Lee, Samuel M; Pusec, Carolina M; Norris, Gregory H; De Jesus, Adam; Diaz-Ruiz, Alberto; Muratalla, Jose; Sarmento-Cabral, Andre; Guzman, Grace; Layden, Brian T; Cordoba-Chacon, Jose.
Afiliación
  • Lee SM; Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Illinois at Chicago, Chicago, Illinois.
  • Pusec CM; Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Illinois at Chicago, Chicago, Illinois.
  • Norris GH; Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Illinois at Chicago, Chicago, Illinois.
  • De Jesus A; Northwestern University, Chicago, Illinois.
  • Diaz-Ruiz A; IMDEA-Food, Madrid, Spain.
  • Muratalla J; Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Illinois at Chicago, Chicago, Illinois.
  • Sarmento-Cabral A; Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Illinois at Chicago, Chicago, Illinois.
  • Guzman G; Department of Pathology, University of Illinois at Chicago, Chicago, Illinois.
  • Layden BT; Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Illinois at Chicago, Chicago, Illinois; Research and Development, Jesse Brown VA Medical Center, Chicago, Illinois.
  • Cordoba-Chacon J; Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Illinois at Chicago, Chicago, Illinois. Electronic address: jcordoba@uic.edu.
Cell Mol Gastroenterol Hepatol ; 11(5): 1291-1311, 2021.
Article en En | MEDLINE | ID: mdl-33444819
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Hepatocitos / PPAR gamma / Enfermedad del Hígado Graso no Alcohólico / Rosiglitazona / Hipoglucemiantes / Inflamación Tipo de estudio: Etiology_studies Límite: Animals Idioma: En Revista: Cell Mol Gastroenterol Hepatol Año: 2021 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Hepatocitos / PPAR gamma / Enfermedad del Hígado Graso no Alcohólico / Rosiglitazona / Hipoglucemiantes / Inflamación Tipo de estudio: Etiology_studies Límite: Animals Idioma: En Revista: Cell Mol Gastroenterol Hepatol Año: 2021 Tipo del documento: Article